Brain O
substrates O
of O
early O
( O
4 O
h O
) O
cigarette O
abstinence O
: O
Identification O
of O
treatment O
targets O
Introduction O
Research O
indicates O
that O
overnight O
nicotine O
abstinence O
disrupts O
neural O
activity O
in O
the O
mesocorticolimbic O
reward O
network O
; O
however O
, O
less O
is O
known O
about O
the O
time O
course O
of O
abstinence-induced O
brain O
changes O
. O

To O
examine O
the O
potential O
neural O
effects O
of O
early O
abstinence O
, O
we O
used O
arterial O
spin O
labeling O
perfusion O
fMRI O
, O
to O
measure O
regional O
cerebral O
blood O
flow O
( O
rCBF O
) O
changes O
in O
the O
resting O
brain O
induced O
by O
4 O
h O
of O
nicotine O
abstinence O
. O

Methods O
In O
a O
repeated O
measures O
design O
, O
5 O
min O
of O
resting O
perfusion O
fMRI O
data O
were O
acquired O
in O
awake O
nicotine-dependent O
individuals O
( O
eyes O
open O
) O
during O
‘ O
smoking O
as O
usual O
’ O
( O
SMK O
) O
and O
following O
4 O
h O
of O
monitored O
nicotine O
abstinence O
( O
ABS O
) O
conditions O
( O
N O
= O
20 O
) O
. O

Conditions O
were O
compared O
using O
a O
paired O
t O
test O
in O
SPM8 O
. O

Craving O
was O
assessed O
prior O
to O
each O
condition O
. O

Results O
Compared O
to O
SMK O
, O
ABS O
significantly O
increased O
craving O
and O
reduced O
rCBF O
in O
select O
regions O
, O
including O
the O
hippocampus O
and O
ventral O
striatum O
( O
cluster O
corr O
, O
α O
= O
0.01 O
, O
943 O
contiguous O
voxels O
) O
. O

The O
magnitude O
of O
the O
abstinence-induced O
change O
in O
rCBF O
correlated O
with O
the O
magnitude O
of O
the O
change O
in O
craving O
across O
conditions O
in O
select O
regions O
, O
including O
the O
medial O
and O
lateral O
orbitofrontal O
cortices O
and O
the O
anterior O
ventral O
insula O
( O
r O
values O
ranging O
from O
0.59–0.74 O
) O
. O

Conclusions O
Results O
show O
that O
as O
few O
as O
4 O
h O
of O
abstinence O
can O
reduce O
resting O
rCBF O
in O
multiple O
nodes O
of O
the O
brain O
’ O
s O
mesocorticolimbic O
network O
, O
disrupting O
neural O
processing O
. O

Identifying O
early O
withdrawal O
treatment O
targets O
has O
far-reaching O
implications O
, O
which O
include O
thwarting O
relapse O
proclivities O
. O

Results O
parallel O
those O
of O
the O
extant O
human O
literature O
and O
are O
in O
agreement O
with O
an O
extensive O
preclinical O
literature O
showing O
compromised O
mesolimbic O
dopaminergic O
function O
and O
impairments O
in O
reward O
function O
during O
nicotine O
withdrawal O
. O

2 O
. O

Methods O
2.1 O
. O

Participants O
The O
study O
was O
conducted O
at O
the O
University O
of O
Pennsylvania O
Perelman O
School O
of O
Medicine O
. O

All O
procedures O
were O
approved O
and O
monitored O
by O
the O
Institutional O
Review O
Board O
, O
and O
adhered O
to O
the O
Declaration O
of O
Helsinki O
. O

Participants O
received O
compensation O
ranging O
from O
$ O
235 O
to O
$ O
250 O
for O
participating O
in O
the O
study O
. O

Eligible O
participants O
were O
non-treatment-seeking O
smokers O
( O
18–60 O
years O
of O
age O
) O
who O
reported O
smoking O
at O
least O
10 O
cigarettes O
per O
day O
for O
the O
past O
3 O
years O
and O
had O
baseline O
carbon O
monoxide O
( O
CO O
) O
levels O
greater O
than O
10 O
ppm O
. O

Ten O
CPD O
was O
chosen O
as O
the O
smoking O
criteria O
to O
study O
the O
effects O
of O
4 O
h O
of O
abstinence O
because O
1 O
) O
10 O
CPD O
represents O
the O
average O
smoker O
in O
the O
current O
climate O
, O
wherein O
smoking O
is O
largely O
prohibited O
in O
the O
work O
place O
and O
most O
other O
public O
places O
in O
the O
U.S O
; O
2 O
) O
a O
10 O
CPD O
individual O
scores O
in O
the O
range O
of O
moderate O
nicotine O
dependence O
on O
the O
FTND O
; O
and O
3 O
) O
ten O
CPD O
corresponds O
to O
approximately O
a O
little O
over O
1 O
cigarette O
over O
the O
course O
of O
two O
hours O
in O
a O
16 O
h O
day O
( O
assuming O
8 O
h O
are O
spent O
sleeping O
) O
, O
thus O
such O
an O
individual O
is O
likely O
to O
experience O
some O
symptoms O
of O
withdrawal O
in O
the O
absence O
of O
nicotine O
over O
a O
4-h O
period O
. O

Participants O
were O
screened O
, O
tested O
on O
study O
knowledge O
, O
and O
consented O
prior O
to O
study O
participation O
. O

Severity O
of O
nicotine O
dependence O
was O
determined O
from O
the O
Fagerström O
Test O
for O
Nicotine O
Dependence O
( O
FTND O
) O
. O

Exclusion O
criteria O
included O
current O
substance O
use O
disorder O
, O
positive O
urine O
drug O
screen O
for O
illicit O
drugs O
( O
tested O
at O
screening O
and O
prior O
to O
MRI O
sessions O
) O
, O
seeking O
treatment O
for O
cigarette/nicotine O
dependence O
or O
attempting O
to O
quit O
smoking O
, O
having O
an O
acute O
, O
chronic O
or O
debilitating O
medical O
condition O
, O
psychiatric O
disorders O
as O
determined O
by O
The O
MINI O
International O
Neuropsychiatric O
Interview O
, O
a O
history O
of O
head O
trauma O
or O
other O
injury O
resulting O
in O
loss O
of O
consciousness O
lasting O
greater O
than O
three O
minutes O
or O
associated O
with O
skull O
fracture O
or O
intra-cranial O
bleeding O
, O
and O
other O
contraindications O
for O
MRI O
, O
and O
head O
movement O
of O
more O
than O
1.5 O
mm O
over O
the O
course O
of O
the O
resting O
baseline O
acquisition O
. O

Following O
MRI O
acquisition O
, O
participants O
with O
abnormal O
structural O
MRIs O
were O
excluded O
( O
N O
= O
2 O
) O
, O
leaving O
20 O
eligible O
participants O
. O

Eligible O
participants O
were O
50 O
% O
male O
and O
the O
majority O
( O
80 O
% O
) O
were O
White O
. O

Other O
races O
included O
1 O
Black O
, O
2 O
Multiple O
Ethnicity O
, O
and O
1 O
Asian O
. O

Participants O
were O
29.1 O
± O
2.13 O
years O
of O
age O
, O
having O
14.75 O
± O
0.52 O
years O
of O
education O
. O

Participants O
smoked O
15 O
. O

± O
1.13 O
cigarettes O
per O
day O
for O
11.0 O
± O
1.87 O
years O
( O
range O
: O
3–33 O
years O
) O
, O
and O
scored O
4.18 O
± O
0.37 O
on O
the O
FTND O
( O
indicating O
moderate O
nicotine O
dependence O
) O
. O

2.2 O
. O

Experimental O
design O
Participants O
participated O
in O
two O
scanning O
sessions O
that O
occurred O
on O
separate O
days O
at O
least O
3 O
or O
more O
days O
apart O
. O

The O
abstinent O
scan O
was O
conducted O
following O
4 O
h O
of O
staff- O
and O
CO-monitored O
nicotine O
abstinence O
. O

Prior O
to O
the O
monitored O
abstinence O
( O
ABS O
) O
regimen O
, O
participants O
smoked O
a O
cigarette O
to O
satiety O
to O
standardize O
time O
since O
last O
smoked O
( O
i.e. O
, O
∼ O
4 O
h O
prior O
to O
MRI O
data O
acquisition O
) O
In O
the O
‘ O
smoking O
as O
usual O
’ O
( O
SMK O
) O
condition O
, O
participants O
smoked O
throughout O
the O
day O
ad O
lib O
, O
were O
monitored O
for O
2 O
h O
prior O
to O
scanning O
while O
continuing O
to O
smoke O
ad O
lib O
, O
and O
smoked O
to O
satiety O
20–25 O
min O
prior O
to O
acquisition O
of O
the O
resting O
baseline O
CBF O
data O
to O
standardize O
time O
since O
last O
smoked O
and O
ensure O
dissipation O
of O
the O
acute O
cardiovascular O
effects O
of O
smoking O
. O

During O
the O
monitoring O
period O
, O
participants O
were O
occupied O
similarly O
, O
filling O
out O
questionnaires O
and O
participating O
in O
various O
computer O
tasks O
. O

Subjective O
reports O
of O
cigarette O
craving O
and O
withdrawal O
were O
obtained O
prior O
to O
each O
condition O
using O
the O
Craving O
and O
Withdrawal O
Questionnaire O
( O
CWQ O
) O
and O
, O
in O
a O
subset O
of O
subjects O
, O
the O
Shiffman-Jarvik O
Scale O
was O
also O
acquired O
( O
n O
= O
14 O
; O
due O
to O
technical O
error O
, O
the O
Shiffman-Jarvik O
was O
omitted O
from O
one O
or O
both O
scanning O
sessions O
in O
6 O
subjects O
) O
. O

Sessions O
were O
counterbalanced O
such O
that O
half O
the O
participants O
were O
scanned O
in O
the O
ABS O
condition O
first O
and O
half O
were O
scanned O
in O
the O
SMK O
condition O
first O
. O

For O
each O
session O
, O
a O
high-resolution O
structural O
scan O
was O
acquired O
first O
, O
followed O
by O
the O
resting O
pseudo O
continuous O
arterial O
spin O
labeled O
( O
pCASL O
) O
perfusion O
fMRI O
scan O
. O

Although O
not O
the O
focus O
of O
the O
current O
investigation O
, O
additional O
scans O
were O
acquired O
subsequently O
. O

Throughout O
the O
scanning O
session O
, O
participants O
were O
instructed O
to O
lie O
still O
in O
the O
scanner O
with O
their O
eyes O
open O
. O

Wakefulness O
was O
verified O
by O
monitoring O
with O
a O
MR-compatible O
video O
camera O
( O
MRC O
Systems O
; O
http O
: O
//www.mrc-systems.de O
) O
. O

2.3 O
. O

MRI O
data O
acquisition O
MRI O
data O
were O
acquired O
on O
a O
Siemens O
3.0 O
T O
Trio O
whole-body O
scanner O
( O
Siemens O
AG O
, O
Erlangen O
, O
Germany O
) O
using O
a O
standard O
8-channel O
receive-only O
array O
head O
coil O
. O

High-resolution O
anatomical O
images O
were O
obtained O
for O
co-registration O
using O
a O
standard O
3-dimensional O
( O
3D O
) O
Magnetization O
Prepared O
Rapid O
Acquisition O
Gradient O
Echo O
( O
MPRAGE O
) O
sequence O
with O
TR O
= O
1620 O
ms O
, O
time O
to O
inversion O
( O
TI O
) O
= O
950 O
ms O
, O
echo O
time O
( O
TE O
) O
= O
3 O
ms O
, O
flip O
angle O
= O
15° O
, O
160 O
contiguous O
slices O
, O
1 O
× O
1 O
× O
1 O
mm O
resolution O
. O

The O
MPRAGE O
sequence O
was O
5 O
min O
in O
duration O
. O

Following O
acquisition O
of O
the O
structural O
scans O
, O
ASL O
perfusion O
images O
were O
acquired O
using O
a O
pseudo-continuous O
ASL O
( O
pCASL O
) O
sequence O
with O
2-dimensional O
( O
2D O
) O
gradient-echo O
echo-planar O
imaging O
( O
GE O
EPI O
) O
with O
a O
delay O
of O
700 O
ms O
inserted O
between O
the O
end O
of O
the O
labeling O
pulse O
and O
image O
acquisition O
and O
the O
following O
parameters O
: O
repetition O
time O
( O
TR O
) O
= O
3.5 O
s O
, O
echo O
time O
( O
TE O
) O
= O
17 O
ms O
, O
labeling O
time O
= O
1.5 O
s O
, O
delay O
time=1s O
, O
flip O
angle=90° O
, O
field O
of O
view O
( O
FOV O
) O
= O
and O
220 O
× O
220 O
mm2 O
, O
matrix O
= O
64 O
× O
64 O
, O
slice O
thickness O
= O
6 O
mm O
, O
inter-slice O
gap O
= O
2 O
mm O
. O

The O
ASL O
resting O
perfusion O
scan O
was O
5 O
min O
in O
length O
, O
providing O
45 O
acquisitions O
. O

2.4 O
. O

Data O
analyses O
Imaging O
data O
analyses O
were O
performed O
using O
Statistical O
Parametric O
Mapping O
software O
( O
SPM8 O
; O
Wellcome O
Department O
of O
Cognitive O
Neurology O
, O
London O
, O
UK O
) O
running O
on O
Matlab O
R2013a O
( O
Math O
Works O
, O
Natick O
, O
MA O
) O
. O

For O
each O
subject O
, O
functional O
images O
were O
realigned O
to O
correct O
for O
head O
motion O
and O
co-registered O
with O
each O
individual O
’ O
s O
anatomical O
image O
. O

Perfusion O
weighted O
image O
series O
were O
then O
generated O
by O
pairwise O
subtraction O
of O
the O
label O
and O
control O
images O
, O
followed O
by O
conversion O
to O
absolute O
CBF O
image O
series O
based O
on O
a O
single O
compartment O
CASL O
perfusion O
model O
. O

For O
each O
subject O
, O
one O
mean O
resting O
CBF O
image O
was O
generated O
, O
normalized O
to O
the O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
template O
, O
smoothed O
with O
a O
3-D O
9 O
mm O
Full O
Width O
Half O
Maximum O
( O
FWHM O
) O
isotropic O
Gaussian O
kernel O
, O
and O
then O
entered O
into O
the O
whole O
brain O
voxel-wise O
analysis O
using O
the O
general O
linear O
model O
( O
GLM O
) O
. O

Age O
and O
sex O
were O
included O
as O
covariates O
in O
all O
analyses O
. O

A O
paired O
t-test O
was O
conducted O
to O
compare O
rCBF O
between O
SMK O
and O
ABS O
conditions O
using O
a O
cluster O
forming O
height O
threshold O
of O
p O
< O
0.001 O
. O

To O
control O
for O
Type O
I O
error O
, O
the O
most O
updated O
and O
accurate O
correction O
method O
for O
controlling O
for O
false O
positives O
provided O
by O
AFNI O
, O
3dttest+ O
+ O
, O
was O
used O
( O
AFNI_17.1.07 O
) O
, O
resulting O
in O
a O
5 O
% O
probability O
of O
a O
cluster O
surviving O
due O
to O
chance O
( O
α O
= O
0.01 O
, O
943 O
contiguous O
voxels O
) O
. O

All O
listed O
coordinates O
are O
in O
MNI O
space O
. O

To O
explore O
associations O
between O
brain O
and O
relevant O
smoking O
behavioral O
measures O
, O
simple O
regression O
analyses O
were O
conducted O
in O
SPM O
on O
the O
change O
in O
rCBF O
from O
SMK O
to O
ABS O
conditions O
, O
using O
the O
change O
in O
craving O
scores O
from O
SMK O
to O
ABS O
conditions O
( O
Item O
3 O
of O
the O
CWQ O
) O
and O
FTND O
scores O
as O
covariates O
of O
interest O
. O

The O
same O
corrections O
used O
for O
rCBF O
contrasts O
were O
applied O
prior O
to O
extracting O
significant O
rCBF O
values O
from O
each O
of O
the O
functionally-identified O
clusters O
within O
each O
subject O
using O
MarsBaR O
and O
statistical O
analyses O
were O
conducted O
in O
SPSS O
version O
22 O
. O

Similarly O
, O
an O
exploratory O
post O
hoc O
analysis O
was O
conducted O
on O
the O
change O
in O
rCBF O
from O
SMK O
to O
ABS O
conditions O
using O
the O
focus/attention O
item O
of O
the O
Shiffman-Jarvik O
Withdrawal O
Scale O
as O
a O
covariate O
of O
interest O
. O

Continuous O
demographic O
variables O
and O
FTND O
scores O
were O
summarized O
by O
calculating O
means O
and O
standard O
error O
measurements O
( O
X O
± O
SEMs O
) O
. O

A O
paired O
t-test O
was O
used O
to O
assess O
differences O
across O
conditions O
in O
CWQ O
items O
and O
the O
focus/attention O
item O
of O
the O
Shiffman-Jarvik O
Scale O
( O
post O
hoc O
) O
. O

Statistical O
analyses O
were O
conducted O
in O
SPSS O
version O
22.0 O
. O

